Atlanta Braves Holdings closed the second quarter of 2026 with a $305.1M consolidated revenue line (down 2.3% from $312.4M a year earlier), a $19.7M baseball-segment Adjusted OIBDA swing from positive to negative, and a $12.1M GAAP net loss, yet the Series C non-voting shares have rallied roughly 8% from the $49.49 open on the August 5 print to the August 14 close of $53.58. The gap is the story: the Q2 baseball segment took a $57.8M Adjusted OIBDA hit on six fewer regular season home games and a $25M jump in major-league player salaries, but the six-month print shows revenue up 4.9% to $377.1M and Mixed-Use Development Adjusted OIBDA up 26% to $38.2M, which is the operating story the market is choosing to underwrite. The load-bearing question for the next six months is whether Baseball-segment Adjusted OIBDA can climb back to positive territory in Q3 on a normal 41-home-game schedule, or whether the current cost base of $252M of Q2 baseball operating costs is the new floor for a team that just traded one Cy Young-caliber arm and a top-10 position-player contract.